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Introduction
Breast cancer is the most common malignant disease in women and one of the main causes of death in developed and developing countries. Although Iran is one of the countries with low incidence of breast cancer than others, the increase in its incidence in recent years has determined the disease as the most common the disease for families raise the necessity of the research for the introduction of new therapeutic substances with immunomodulatory properties and fewer side effects (3) (4) (5) .
Today, compounds with immunolodulator properties can be replaced with routine drugs.
Deacetylchitin is one of them. Chitin and its derivatives such as chitosan -carboxymethyl chitin, and dihydroxypropyl chitin have immune modulatory effects and increase cell activity, secretion of cytokines and chemokines by affecting on the innate and adaptive immune system. Since chitin and its derivatives do not exist in the structure of the human body, its presence is an activator of the immune system and some receptors such as Detectin-1, TLR-2 and mannose are responsible for identifying it on the surface of immune cells.
Suspension and Deacetylchitin particles have the ability to stimulate the immune system as chemotaxis and activation of macrophages (6) (7) (8) (9) (10) (11) .
Given the importance of the immune system, especially cellular immune responses in anti-tumor defense and its overcome to humoral immunity as an important factor in anti-tumor defense, the activity can cause the death of cancer cells if Deacetylchitin nanoparticles lead the activation of the immune system and spleen cell proliferation. Therefore, the combination with other anticancer drugs will be discussed as a combination of immune booster and immunolodulator.
The aim of this study was to evaluate the stimulation of immune cells and third proliferation in the interaction with Deacetylchitin nanoparticles.
Materials and Methods
This study is interventional. 1 mg per ml of Deacetylchitin was dissolved initially in 1% acetic acid solution for production and preparation of nanoparticles.
Deacetylchitin solution was put on the stirrer with a speed of 400 at room temperature. Tripolyphosphate (TPP) 0.1% was prepared in distilled water and TPP solution was added once to Deacetylchitin using ion gel method. The reaction continued for 1 hour under these conditions. Electron microscope was used to study the characteristics of bonded particles, their shape, size, dispersion and uniformity and ZETA SIZER (Malvern) was used to determine the electrical charge.
Nanoparticles had been isolated from free Deacetylchitin parts using centrifuges at a speed of 18,000 rpm for 30 minutes at 15 ° C (14, 15) . To test to 570 of controls (18) .
Statistical analysis:
This study is interventional. Data was reported as mean ± SD and statistical analysis of test data was performed using variance (ANOVA) followed by Tukey test.
Results were reviewed using SPSS and Prism6 and P≤0.001 was interpreted as significant.
Results
Particle size, distribution and uniformity of Deacetylchitin have been determined by DLS (Malvern). Figure 1 shows Deacetylchitin particles size at pH 6 and the average size of the nanoparticles was 210 nm after three replications. DLS device data on the sample revealed that the size range of more than 95 percent of the tested samples were 210 nm with higher peak and about 5 percent of the others were in the range of 20 to 70 nm with an average of 45 nm. Figure 2 shows Deacetylchitin nanoparticles electric charge at pH 6. An average electric charge of Deacetylchitin with three replications was determined as 11+ mV. DLS device data showed that the graph was single peak with homology. The electron beam interaction with the matter particles showed the appearance of nanoparticles. Beams emitted from these interactions can be used to survey. Figure 2 shows Deacetylchitin nanoparticles images in SEM microscope. Downloaded from umj.umsu.ac.ir at 16:03 +0330 on Thursday March 5th 2020 However, tumor untreated groups and less healthy rats showed less growth compared with the control group and this difference was statistically significant (P> 0.05). Figure 1 
clearly shows an increased
Deacetylchitin nanoparticles stimulatory effect on these cells. and cell proliferation cause the immune system to activate which causes cells not to be neutral against cancer cell and exhibits an appropriate response. The type of activation path is important. Since reduction in tumor size was observed followed by the activation of the system and the proliferation of clones, it can be understood that the reduction can be achieved by activating the pathway Th1 and cell safety which reduces the size of the tumor cell. The exact molecular mechanism of reduction in tumor size is discussed in the case group which was direct and through the cytotoxic effect of nanoparticles, or indirect through inhibition of the immune system leading reduction in size requiring further studies.
N a n o p a r t i c l e s u n t r e a t e d c o n t r o l
Due to the unique features, Deacetylchitin nanoparticles will not only be discussed to deliver a variety of drugs and anticancer drugs, but also as a treatment option along with supplements. Therefore, future studies are necessary to assess the impact of Deacetylchitin on the various signaling pathways and anti-tumor activity.
